Author

Gourab Gupta

University of South Carolina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:metagenomics· 1

Frequent Co-Authors

Conor PulliamiD· 2 shared Dan XueiD· 2 shared Hexin CheniD· 2 shared Jie LiiD· 2 shared Mingming XuiD· 2 shared Zhuo ShangiD· 2 shared Armando SardiiD· 1 shared Daping FaniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Conor PulliamORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genome Mining of the Tumor Microbiome Reveals Biosynthetic Diversity and Potential Tumor-modulating Metabolites

Conor Pulliam, Mingming Xu, Katherine S. Holandez-Lopez, Dan Xue, Zhuo Shang, Gourab Gupta, Olivia E. Dioli, Leilei Gou, Jennifer S. Brodbelt, Xuefeng Peng, Hexin Chen, Jie Li

The paper surveys the biosynthetic potential of the human tumor microbiome, identifying novel metabolites and their potential roles in tumor pathology.

bioRxiv · Aug 11, 2026 · PreprintMicrobiology

Discovery of A Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads

Dan Xue, Mingming Xu, Michael D. Madden, Xiaoying Lian, Ethan A. Older, Conor Pulliam, Yvonne Y. Hui, Zhuo Shang, Gourab Gupta, Manikanda Raja Keerthi Raja, Yuzhen Wang, Armando Sardi, Yaoling Long, Hexin Chen, Daping Fan, , Jie Li

This paper discovers a new class of cancer immunogenic chemotherapeutic leads called aspercyclicins through a high-throughput screening platform and structural elucidation techniques.

Journal of the American Chemical Society · Dec 28, 2024Peer-reviewedBiochemistry